Aberrant Wnt activation, influenced by FAT atypical cadherin 1 (FAT1) mutations, enhances tumor progression, whereas sonic hedgehog signaling promotes Nanog expression and drug efflux transporter activity, further increasing chemoresistance.196 GSCs contribute to GBM relapse by resisting conventional therapies. The gene discussed is FAT1; the disease is neoplasm.